BRIEF-Iovance Biotherapeutics Q2 Revenue USD 99.313 Million
Reuters2026/08/06 11:02Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Aug 06 (Reuters) - Iovance Biotherapeutics Q2 net income USD -47.315 million vs. IBES estimate USD -57.6 million.
- Q2 operating income USD -51.905 million vs. IBES estimate USD -59.7 million
- Q2 pretax profit USD -48.688 million vs. IBES estimate USD -59.8 million
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Market Chatter: Dow Mulls Exit From $20 Billion Chemicals Partnership With Saudi Aramco
MT newswire•2026/09/09 11:57
Datavault AI faces shareholder securities lawsuit targeting company, officers
Reuters•2026/09/09 11:56
Terregra Asia Energy assets fall 54.98% in FY2025 to Rp 206.45 billion
Reuters•2026/09/09 11:55
Seaport Therapeutics Says GlyphAllo Shows no Next-Morning Driving Impairment in Phase 1 Trial
MT newswire•2026/09/09 11:54
Crypto prices
More
Bitcoin
BTC
$79,292.07
+1.21%
Ethereum
ETH
$2,503.97
+1.24%
Tether USDt
USDT
$0.9997
+0.01%
BNB
BNB
$749.64
-0.24%
XRP
XRP
$1.43
+2.45%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$104.23
+1.45%
TRON
TRX
$0.3393
+0.25%
Hyperliquid
HYPE
$86.16
+3.74%
Zcash
ZEC
$1,269.35
+9.82%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now